Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Heart Journal

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1067/MHJ.2001.113573PMID 11275926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

  1998cited by this paper
• Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization.

  1997cited by this paper
• Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization.

  1997cited by this paper
• Effects of Cigarette Smoking on the Angiographic Evolution of Coronary Atherosclerosis: A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy

  1996cited by this paper
• Cigarette smoking among adults--United States, 1994.

  1996cited by this paper
• Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group.

  1996cited by this paper
• Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function.

  1995cited by this paper
• Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction.

  1995cited by this paper
• Diminished Vascular Response to Inhibition of Endothelium‐Derived Nitric Oxide and Enhanced Vasoconstriction to Exogenously Administered Endothelin‐1 in Clinically Healthy Smokers

  1994cited by this paper
• Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both.

  1994cited by this paper
• Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

  1994cited by this paper
• Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction

  1993cited by this paper
• Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction.

  1993cited by this paper
• Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Myocardial Infarction

  1991cited by this paper
• Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking.

  1990cited by this paper
• Cigarette smoking and hemostatic function.

  1988cited by this paper
• Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

  1987cited by this paper
• Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

  1987cited by this paper
• Falsely raised plasma digoxin concentrations in liver disease.

  1985cited by this paper
• Epidemiological characteristics of platelet aggregability.

  1985cited by this paper
• Fibrinogen as a risk factor for stroke and myocardial infarction.

  1984cited by this paper
• Platelet Survival and the Development of Coronary Artery Disease in the Young Adult: Effects of Cigarette Smoking, Strong Family History and Medical Therapy

  1981cited by this paper

• Device Therapy in Ischemic Heart Disease : Are we there yet ?

  2021cites this paper
• Smoking and Platelet Function

  2014cites this paper
• Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).

  2014cites this paper
• Long-term effect of persistent smoking on the prognosis of Chinese male patients after percutaneous coronary intervention with drug-eluting stent implantation.

  2013cites this paper
• INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Review Article

  2012cites this paper
• Abciximab

  2012cites this paper
• Smokers with ST-segment elevation myocardial infarction and short time to treatment have equal effects of PCI and fibrinolysis.

  2012cites this paper
• Cigarette smoking inhibits the anti-platelet activity of aspirin in patients with coronary heart disease.

  2011cites this paper
• Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE)

  2011cites this paper
• 94 6 M is e a u p o in t Bénéfices cardiovasculaires du sevrage tabagique

  2009cites this paper
• Deutsche Leitlinie zur Rehabilitation von Patienten mit Herz-Kreislauferkrankungen (DLL-KardReha)

  2007cites this paper
• Planned versus provisional use of glycoprotein IIb/IIIa inhibitors in smokers undergoing percutaneous coronary intervention.

  2006cites this paper
• Influence of Smoking on Predictors of Vascular Disease

  2003cites this paper
• Spotlight on Abciximab in Patients with Ischemic Heart Disease Undergoing Percutaneous Coronary Revascularization

  2003cites this paper
• Results of systematic review of research on diagnosis and treatment of coronary heart disease in women.

  2003cites this paper
• Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease.

  2003cites this paper
• Clinical trials with glycoprotein IIb/IIIa antagonists - No benefit without bleeding?

  2001cites this paper